Immunologic reactions triggered during irritant contact dermatitis

American Journal of Contact Dermatitis

Volumn 9, Issue 2, 1998, Pages 107-110

  Nickoloff, Brian J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; BIOPHYSICS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; IRRITANT DERMATITIS; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; STRATUM CORNEUM; T LYMPHOCYTE;

EID: 0031862242     PISSN: 1046199X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-199X(98)90006-9     Document Type: Article

References (43)

1. Singer SJ, Nicholson GL: The fluid mosaic model of the structure of cell membranes. Science 175:720-731, 1972
2. Elias PM: Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80:44-49, 1983 (suppl)
3. Forslind B: A domain mosaic model of the skin barrier. Acta Derm Venereol 74:1-6, 1994
4. Nickoloff BJ: Keratinocytes as initiators of inflammatory and immune reactions of the skin. In Vitro Toxicol 8:405-409, 1996
5. Nickoloff BJ, Turka LA: Keratinocytes: Key immunocytes of the integument. Am J Pathol 143:325-331, 1993
6. Hanley K, Rassner U, Elias PM, et al: Epidermal barrier ontogenesis: Maturation in serum-free media and acceleration by glucocorticoids and thyroid hormones but not selected growth factors. J Invest Dermatol 106:404-411, 1996
7. Luger TA, Schwartz T: Evidence for an epidermal cytokine network. J Invest Dermatol 95:100-104, 1990
8. Kupper TS: Immune and inflammatory process in cutaneous tissues: Mechanism and speculation. J Clin Invest 86:1783-1785, 1990
9. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-245, 1994
10. Romangnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
11. Powrie F, Coffman RL: Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol Today 14:270-274, 1993
12. Nickoloff BJ, Griffiths CEM, Barker JNWN: The role of adhesion molecules, chemotactic factors and cytokines in inflammatory and neoplastic skin diseases. J Invest Dermatol 94:151-157, 1990 (suppl)
13. Barker JNWN, Mitra RS, Griffiths CEM, et al: Keratinocytes as initiators of inflammation. Lancet 337:211-214, 1991
14. Nickoloff BJ: Role of epidermal keratinocytes as key initiators of contact dermatitis due to allergic sensitization and irritation. Am J Contact Dermatitis 3:65-69, 1992
15. Landsteiner K, Jacobs J: Studies on the sensitization of animals with simple chemical compounds. J Exp Med 61:643-655, 1935
16. Kinnaird A, Peters SW, Foster JR, et al: Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Immunol 89:202-210, 1989
17. Kripke ML, Dunn CG, Jeevan A, et al: Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833-2838, 1990
18. Aiba S, Katz SI: Phenotype and functional characteristics of in-vivo-activated Langerhans cells. J Immunol 145:2791-2796, 1990
19. Cumberbatch M, Kimber I: Dermal tumor necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides a stimulus for Langerhans cell migration. Immunology 75:257-263, 1992
20. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
21. Griffiths CEM, Barker JNWN, Kunkel S, et al: Modulation of leukocyte adhesion molecules, T cell chemotaxins and a regulatory cytokine in allergic contact dermatitis. Br J Dermatol 124:519-526, 1991
22. Gahring LC, Buckley A, Daynes RA: Presence of epidermal derived thymocyte activating factor/interleukin-1 in normal human stratum corneum. J Clin Invest 76:1585-1591, 1985
23. Hauser C, Saurat JH, Schmitt A, et al: Interleukin-1 is present in normal human epidermis. J Immunol 136:3317-3321, 1986
24. Didrerjean L, Salomon D, Merot Y, et al: Localization and characterization of the interleukin-1 immunoreactivity in normal human epidermis. J Invest Dermatol 92:809-816, 1989
25. Camp RDR, Fincham NJ, Ross J, et al: Potent inflammatory properties of interleukin-1 alpha-like material isolated from normal human skin. J Invest Dermatol 94:735-741, 1990
26. Kolde G, Schulze-Osthoff K, Meyer H, et al: Immunohistological and immunoelectron microscope identification of TNF-α in normal human and murine epidermis. Arch Dermatol Res 284:154-158, 1992
27. Groves RW, Sherman L, Mizutani H, et al: Detection of interleukin-1 receptors in human epidermis. Am J Pathol 145:1048-1056, 1994
28. Colotta F, Dower SK, Sims JE, et al: The type II decoy receptor: A novel regulatory pathway for interleukin-1. Immunol Today 15:562-566, 1994
29. Piguet PF, Grau GE, Hauser G: Tumor necrosis factor is a central mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679, 1996
30. Haas J, Lipkow T, Mohamadzandeh M, et al: Inflammatory cytokines in murine keratinocytes upon in vivo stimulation with contact sensitizers and tolerizing analogaes. Exp Dermatol 1:76-83, 1997
31. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
32. Willis GM, Stephens CJM, Wilkinson JD: Selective expression of immune associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 96:505-511, 1991
33. Fisher G, Esmann J, Griffiths CEM, et al: Cellular, biochemical, and immunological characterization of topical retinoic acid treated human skin. J Invest Dermatol 96:699-707, 1991
34. Wilmer JL, Burleson FG, Kayama F, et al: Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical induced inflammation in mouse skin. J Invest Dermatol 102:915-922, 1994
35. Woud LC, Jackson SM, Elias PM, et al: Cutaneousbarrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992
36. Nickoloff BJ, Naidu Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546, 1994
37. Proksch E, Feingold KR, Man MQ, et al: Barrier function of regulator epidermal DNA synthesis. J Clin Invest 87:1688-1673, 1991
38. Tsai JC, Feingold KR, Crumrine D, et al: Permeability barrier disruption alters the localization and expression of TNF alpha protein in the epidermis. Arch Dermatol Res 286:242-248, 1994
39. Ghadially R, Reed JT, Elias PM: Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 558-564, 1996
40. Woud LC, Elias PM, Calhoun C, et al: Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
41. Lee SH, Elias PM, Proksch E, et al: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-538, 1992
42. Ghadially R, Reed JT, Elias PM: Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107:558-564, 1996
43. Haratake A, Uchida Y, Suhmuth M, et al: UVB-induced alterations in permeability barrier function: Roles for epidermal hyperproliferation and thymocyte-mediated response. J Invest Dermatol 108:769-775, 1997